论文部分内容阅读
目的 :评价用莫西沙星与左氧氟沙星治疗下呼吸道感染的临床疗效及安全性。方法 :将 5 4例下呼吸道感染患者随机分成治疗组 2 6例和对照组 2 8例 ,分别给予莫西沙星和左氧氟沙星治疗。结果 :研究结果显示治疗结束后第 7d ,莫西沙星组和左氧氟沙星组的临床有效率分别为 6 0 %和 6 3.16 % ,莫西沙星 2 6例中 5例 (19.2 3% )出现不良反应 ,而左氧氟沙星 2 8例中为 7例 (2 5 % )。结论 :莫西沙星对治疗下呼吸道感染的临床疗效确切、安全性高
Objective: To evaluate the clinical efficacy and safety of moxifloxacin and levofloxacin in the treatment of lower respiratory tract infection. Methods: 54 cases of lower respiratory tract infection were randomly divided into treatment group 26 cases and control group 28 cases, were given moxifloxacin and levofloxacin treatment. Results: The results showed that on the 7th day after treatment, the clinical effective rates of the Moxifloxacin group and the levofloxacin group were 60% and 6 3.16%, respectively. Among the 26 cases of Moxifloxacin, 5 (19.2%) showed adverse reactions, In levofloxacin 28 cases, 7 cases (25%). Conclusion: Moxifloxacin is effective and safe for the treatment of lower respiratory tract infection